COVID-19 and cancer: start the resolution! Chantal BarksdaleFranciele C. KipperDipak Panigrahy COMMENTARY 21 February 2022 Pages: 1 - 15
Lipid metabolism reprogramming in renal cell carcinoma Gioia HeraviOmid YazdanpanahWanqing Liu Non-Thematic Review 06 November 2021 Pages: 17 - 31
Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology Esteban Javier RozenJason Matthew Shohet Non-Thematic Review Open access 30 October 2021 Pages: 33 - 52
Glioma: molecular signature and crossroads with tumor microenvironment Lennart BarthelMartin HadamitzkySusann Hetze Review Open access 23 October 2021 Pages: 53 - 75
MicroRNAs as a clue to overcome breast cancer treatment resistance Iris Garrido-CanoBirlipta PattanayakPilar Eroles ReviewPaper Open access 15 September 2021 Pages: 77 - 105
Glycosylation as a regulator of site-specific metastasis Wendy E. BindemanBarbara Fingleton Non-Thematic Review 30 December 2021 Pages: 107 - 129
Emerging roles of epithelial-mesenchymal plasticity in invasion-metastasis cascade and therapy resistance Minal Garg Non-Thematic Review 03 January 2022 Pages: 131 - 145
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective David G. MenterVahid Afshar-KharghanAnil K. Sood Non-Thematic Review 12 January 2022 Pages: 147 - 172
The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers Ying ShaoBingjian Lu CLINICAL 18 October 2021 Pages: 173 - 191
Anti-HER2 therapy in metastatic breast cancer: many choices and future directions Carrie S. WynnShou-Ching Tang Clinical Open access 10 February 2022 Pages: 193 - 209
Adipocytokines and disease progression in endometrial cancer: a systematic review Irene RayLisiane B. MeiraPatricia E. Ellis CLINICAL Open access 24 December 2021 Pages: 211 - 242